To assess the rate of bone loss in patients with inflammatory bowel di
sease, we prospectively studied 35 patients (17 women) aged 36 +/- 13
(range 17-60) years, 14 of whom had Crohn's disease and 21 with ulcera
tive colitis (including 12 with ileoanal anastomosis). Bone mineral de
nsity was measured by dual-energy X-ray absorptiometry at the lumbar s
pine and femoral neck. The follow-up was 19 +/- 8 months. During this
period, 14 patients received oral steroids. Lumbar bone density change
s expressed as a percentage per year were -3.1 +/- 4.9%, -6.4 +/- 7.5%
and +2.0 +/- 4.0% in Crohn's disease and ulcerative colitis without a
nd with ileoanal anastomosis respectively (p = 0.007). The same patter
n was observed at the femoral neck. Mean annual lumbar bone density ch
anges were -6.2 +/- 7.0% and +0.9 +/- 3.9% in patients with and withou
t steroids during follow-up (p = 0.002). We conclude that patients wit
h inflammatory bowel disease are at risk of lumbar and femoral bone lo
ss. However, bone loss is not observed in patients with ileoanal anast
omosis.